259 related articles for article (PubMed ID: 12647675)
1. New questions about an old combination--ddI + d4T.
Proj Inf Perspect; 2003 Jan; (35):13-4. PubMed ID: 12647675
[TBL] [Abstract][Full Text] [Related]
2. Combining d4T/ddI looks promising.
Posit Aware; 1996; 7(1):7. PubMed ID: 11363129
[TBL] [Abstract][Full Text] [Related]
3. d4T plus ddI: warning for pregnant women.
AIDS Treat News; 2001 Jan; (358):8. PubMed ID: 12173560
[TBL] [Abstract][Full Text] [Related]
4. ddI and d4T plus protease inhibitors.
GMHC Treat Issues; 1996 Nov; 10(11):8-9. PubMed ID: 11364012
[TBL] [Abstract][Full Text] [Related]
5. New uses for tenofovir: more questions about d4T.
Proj Inf Perspect; 2003 Jan; (35):15-6. PubMed ID: 12647676
[TBL] [Abstract][Full Text] [Related]
6. Studies of zidovudine in combination with didanosine and zalcitabine.
Jablonowski H
J Acquir Immune Defic Syndr Hum Retrovirol; 1995; 10 Suppl 1():S52-6. PubMed ID: 8595509
[TBL] [Abstract][Full Text] [Related]
7. What they say about nucleoside drugs.
Posit Aware; 1999; 10(1):28-34. PubMed ID: 11366520
[TBL] [Abstract][Full Text] [Related]
8. Tenofovir drug interactions: ddI and d4T.
TreatmentUpdate; 2003; 15(2):7. PubMed ID: 12693363
[No Abstract] [Full Text] [Related]
9. What we know about anti-HIV drugs.
Treat Rev; 1995 May; (no 18):3-4. PubMed ID: 11362592
[TBL] [Abstract][Full Text] [Related]
10. The role of nucleoside reverse transcriptase inhibitors usage in the incidence of hyperlactatemia and lactic acidosis in HIV/AIDS patients.
Dragovic G; Jevtovic D
Biomed Pharmacother; 2012 Jun; 66(4):308-11. PubMed ID: 22658063
[TBL] [Abstract][Full Text] [Related]
11. Randomized, open-label, comparative trial to evaluate the efficacy and safety of three antiretroviral drug combinations including two nucleoside analogues and nevirapine for previously untreated HIV-1 Infection: the OzCombo 2 study.
French M; Amin J; Roth N; Carr A; Law M; Emery S; Drummond F; Cooper D;
HIV Clin Trials; 2002; 3(3):177-85. PubMed ID: 12032876
[TBL] [Abstract][Full Text] [Related]
12. [Conditions of "thymidine analog mutations" (TAMs) in naive patients treated with different combinations of d4T].
Mouroux M; Izopet J; Descamps D; Delaugerre C; Yvon-Groussin A; Angleraud F; Coutellier A; Bonmarchand M; Valantin MA; Matheron S; Agut H; Katlama C; Brun-Vezinet F; Calvez V
Pathol Biol (Paris); 2000 Jun; 48(5):508-12. PubMed ID: 10949850
[TBL] [Abstract][Full Text] [Related]
13. ddI, d4T, Hydroxyurea: new pancreatitis warning.
AIDS Treat News; 1999 Nov; (No 331):1-3. PubMed ID: 11367125
[TBL] [Abstract][Full Text] [Related]
14. Dethroning AZT.
Gilden D; Falkenberg J; Torres G
GMHC Treat Issues; 1997 Feb; 11(2):10-3. PubMed ID: 11364106
[TBL] [Abstract][Full Text] [Related]
15. In vitro analysis of synergism and antagonism of different nucleoside/nucleotide analogue combinations on the inhibition of human immunodeficiency virus type 1 replication.
Perez-Olmeda M; Garcia-Perez J; Mateos E; Spijkers S; Ayerbe MC; Carcas A; Alcami J
J Med Virol; 2009 Feb; 81(2):211-6. PubMed ID: 19107982
[TBL] [Abstract][Full Text] [Related]
16. Tenofovir: new indication. For first-line antiretroviral therapy: wait and see.
Prescrire Int; 2004 Oct; 13(73):180-2. PubMed ID: 15499699
[TBL] [Abstract][Full Text] [Related]
17. Combination therapy for patients with HIV-1 infection: the use of dual nucleoside analogues with protease inhibitors and other agents.
Gulick R
AIDS; 1998; 12 Suppl 3():S17-22. PubMed ID: 15168719
[TBL] [Abstract][Full Text] [Related]
18. Nucleoside analogue mutations and Q151M in HIV-1 subtype A/E infection treated with nucleoside reverse transcriptase inhibitors.
Sirivichayakul S; Ruxrungtham K; Ungsedhapand C; Techasathit W; Ubolyam S; Chuenyam T; Emery S; Cooper D; Lange J; Phanuphak P
AIDS; 2003 Sep; 17(13):1889-96. PubMed ID: 12960821
[TBL] [Abstract][Full Text] [Related]
19. New antiretrovirals and new combinations.
Havlir DV; Lange JM
AIDS; 1998; 12 Suppl A():S165-74. PubMed ID: 9632999
[TBL] [Abstract][Full Text] [Related]
20. Incidence of neuropathy in HIV-infected patients on monotherapy versus those on combination therapy with didanosine, stavudine and hydroxyurea.
Moore RD; Wong WM; Keruly JC; McArthur JC
AIDS; 2000 Feb; 14(3):273-8. PubMed ID: 10716503
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
